Denkert C - Search Results

1

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients.

Baccelli I, Stenzinger A, Vogel V, Pfitzner BM, Klein C, Wallwiener M, Scharpff M, Saini M, Holland-Letz T, Sinn HP, Schneeweiss A, Denkert C, Weichert W, Trumpp A. Baccelli I, et al. Among authors: denkert c. Oncotarget. 2014 Sep 30;5(18):8147-60. doi: 10.18632/oncotarget.2385. Oncotarget. 2014. PMID: 25230070 Free PMC article.

2

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S. Kristiansen G, et al. Among authors: denkert c. Am J Pathol. 2002 Oct;161(4):1215-21. doi: 10.1016/S0002-9440(10)64398-2. Am J Pathol. 2002. PMID: 12368195 Free PMC article.

3

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I. Kristiansen G, et al. Among authors: denkert c. Br J Cancer. 2003 Jan 27;88(2):231-6. doi: 10.1038/sj.bjc.6600702. Br J Cancer. 2003. PMID: 12610508 Free PMC article.

4

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

5

Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.

Weichert W, Gekeler V, Denkert C, Dietel M, Hauptmann S. Weichert W, et al. Among authors: denkert c. Int J Oncol. 2003 Sep;23(3):633-9. Int J Oncol. 2003. PMID: 12888898

6

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.

Denkert C, Fürstenberg A, Daniel PT, Koch I, Köbel M, Weichert W, Siegert A, Hauptmann S. Denkert C, et al. Oncogene. 2003 Nov 27;22(54):8653-61. doi: 10.1038/sj.onc.1206920. Oncogene. 2003. PMID: 14647459

7

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S. Denkert C, et al. Cancer Res. 2004 Jan 1;64(1):189-95. doi: 10.1158/0008-5472.can-03-1987. Cancer Res. 2004. PMID: 14729623

8

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.

Weichert W, Denkert C, Schmidt M, Gekeler V, Wolf G, Köbel M, Dietel M, Hauptmann S. Weichert W, et al. Among authors: denkert c. Br J Cancer. 2004 Feb 23;90(4):815-21. doi: 10.1038/sj.bjc.6601610. Br J Cancer. 2004. PMID: 14970859 Free PMC article.

9

Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.

Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, Loening S, Dietel M, Kristiansen G. Weichert W, et al. Among authors: denkert c. Prostate. 2004 Aug 1;60(3):240-5. doi: 10.1002/pros.20050. Prostate. 2004. PMID: 15176053

10

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.

Denkert C, Weichert W, Winzer KJ, Müller BM, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S. Denkert C, et al. Clin Cancer Res. 2004 Aug 15;10(16):5580-6. doi: 10.1158/1078-0432.CCR-04-0070. Clin Cancer Res. 2004. PMID: 15328200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters